Beckley Academy, a leading training organisation that prepares and trains practitioners with a focus on preparing mental health professionals to use ketamine, psilocybin, and MDMA to treat patients, announced today that Sara Gael Beauregard and Mary Sanders have joined the team as facilitators. Both Sara and Mary are psychedelic therapists with clinical experience working with training organisations to meet the increasing demand for experienced and credentialed therapists able to train practitioners in the administration and facilitation of psychedelic therapies.
Mary Sanders, LCSW, is a psychotherapist and social justice advocate exploring transgenerational trauma with BIPOC, 2SLGBT, veterans, immigrants, refugees, and foster youth. Mary has completed training at CIIS CPTR, MAPS, and the Ketamine Training Centre and is certified in trauma-focused cognitive behavioural therapy. She is also a founding board member of the People of Colour Psychedelic Collective. She is passionate about exploring collective healing through an intersectional lens and facilitates conversations around community-oriented infrastructures that centre accessibility and culturally attuned care.
Sara Gael Beauregard, MA, LPC, is a psychedelic therapist, educator, and mentor with expertise in MDMA-assisted therapy, ketamine-assisted therapy, and psychedelic risk reduction. She has operated as an investigator for MAPS Public Benefit Corporation Phase 2 and Phase 3 clinical trials, researching the safety and efficacy of MDMA-assisted therapy for PTSD. Currently serving as a MAPS PBC lead educator and associate supervisor, she is also the lead facilitator and former course director for the Integrative Psychiatry Institute Psychedelic-assisted therapy training.
“Learning and growth happen in relationships. At Beckley Academy, we foster the relationship between learners and faculty by approaching the online classroom as a time for rich discussion, reflection, and embodied skills practice,” said Deborah Gardner, head of education for Beckley Academy. “Mary and Sara join faculty Karina Sergi and Danielle Herrera, who together represent diverse PAT experience drawing from clinical trials with MAPS, Beckley PsyTech, and ketamine-assisted therapy.”
Beckley Academy, co-founded by Beckley Waves and guided by Amanda Feilding, stems from the research and contributions of the Beckley Foundation, which is at the forefront of shaping global drug policy. Beckley Academy received its first investment from Beckley Waves, Amanda Feilding’s catalytic venture studio, to become the leading training organisation with a focus on preparing mental health professionals to use ketamine, psilocybin, and MDMA to treat patients.
“Course content and instructional design are important components of a training programme, but the programme is only as good as the instructors who bring the course material to life,” said John Yoo, CEO of Beckley Academy. “We’re thrilled and honoured to have Sara and Mary join our team, giving voice to women and women of colour in this emerging space.”